Gray, M. A.; Seeler, M.; Montoya, C.; Park, J.; Mai, L. D.; Whitehead, K. A.; Champion, J. A.

Although biomacromolecules require intracellular delivery for therapeutic effect, existing transfection agents are often characterized by high cost, low efficiency, and/or cytotoxicity. Here, we describe a new transfection approach based on hydrophobic ion pairing (HIP), which involves the simple mixing of a hydrophobic counterion with charged biomacromolecules. Among tested cargoes (proteins, siRNA, and pDNA), the HIP siRNA system performed especially well, achieving silencing in fibroblasts (80%), T cells (90%), and neurons (70%). HIP siRNA was also highly potent in mice, with tropism dependent on the route of administration. Most notably, intraperitoneal administration enabled ~40% LAMP-1 knockdown in the pancreas, and intravenous delivery resulted in a remarkable 80% silencing in the heart. Heart delivery was also highly selectively, with no significant knockdown in the liver. Together, these data demonstrate a new, inexpensive approach to biomacromolecular delivery with the potential to target difficult-to-transfect organs, thus expanding the therapeutic potential of nucleic acids.